| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/03/2023 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 933.3k | $0.00 | $0 | | 07/03/2023 |
| 05/22/2023 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 12.1k | $25.74 | $310.3k | | 05/22/2023 |
| 05/22/2023 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 6k | $0.00 | $0 | | 05/22/2023 |
| 05/18/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 3.5k | $189.87 | $655.8k | | 05/18/2023 |
| 03/01/2023 | Vir Biotechnology, Inc. | VIR | Purchase | Common Stock | 2.5k | $22.73 | $56.8k | By Sigal Family Investments, LLC | 03/01/2023 |
| 01/04/2023 | Vir Biotechnology, Inc. | VIR | Purchase | Common Stock | 2.5k | $25.25 | $63.1k | By Sigal Family Investments, LLC | 01/03/2023 |
| 01/03/2023 | Vir Biotechnology, Inc. | VIR | Purchase | Common Stock | 2.5k | $25.60 | $64k | By Sigal Family Investments, LLC | 01/03/2023 |
| 08/22/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4.5k | $217.91 | $971k | | 08/22/2022 |
| 07/01/2022 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 737k | $0.00 | $0 | | 07/01/2022 |
| 06/08/2022 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 24k | $2.01 | $48.2k | | 06/08/2022 |
| 05/23/2022 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 12.8k | $24.14 | $309.2k | | 05/23/2022 |
| 05/23/2022 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 6.4k | $0.00 | $0 | | 05/23/2022 |
| 07/01/2021 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 474.4k | $0.00 | $0 | | 07/01/2021 |
| 06/08/2021 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 17.7k | $7.69 | $136.1k | | 06/08/2021 |
| 05/21/2021 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 3.4k | $0.00 | $0 | | 05/21/2021 |
| 05/21/2021 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 6.7k | $45.28 | $305.5k | | 05/21/2021 |
| 07/10/2020 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 57.8k | $48.71 | $2.8M | | 07/10/2020 |
| 07/10/2020 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 28.4k | $48.71 | $1.4M | | 07/10/2020 |
| 07/01/2020 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 184.3k | $0.00 | $0 | | 07/01/2020 |
| 06/10/2020 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 12k | $4.35 | $52.2k | | 06/10/2020 |
| 10/01/2019 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 13.6k | $1.17 | $15.9k | | 10/01/2019 |
| 07/02/2019 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 234.4k | $0.00 | $0 | | 07/02/2019 |
| 06/05/2019 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 12.1k | $3.69 | $44.6k | | 06/05/2019 |
| 07/02/2018 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 8.9k | $16.83 | $149.5k | | 07/02/2018 |
| 06/22/2018 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 154.8k | $0.00 | $0 | | 06/22/2018 |
| 04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Common Stock | 45.5k | $0.00 | $0 | See Footnote | 04/23/2018 |
| 04/23/2018 | Surface Oncology, Inc. | SURF | Conversion | Series A Preferred Stock | 100k | $0.00 | $0 | See Footnote | 04/23/2018 |
| 07/03/2017 | Adaptimmune Therapeutics PLC | ADAP | Grant | Option to purchase Ordinary Shares | 220.8k | $0.00 | $0 | | 07/03/2017 |